|
1
|
Cordon-Cardo C, Pujadas E, Wajnberg A,
Sebra R, Patel G, Firpo-Betancourt A, Fowkes M, Sordillo E,
Paniz-Mondolfi A, Gregory J, et al: COVID-19: Staging of a new
disease. Cancer Cell. 38:594–597. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ucciferri C, Vecchiet J and Falasca K:
Role of monoclonal antibody drugs in the treatment of COVID-19.
World J Clin Cases. 8:4280–4285. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Singh AK, Gupta R, Ghosh A and Misra A:
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and
practical considerations. Diabetes Metab Syndr. 14:303–310.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huang I, Lim MA and Pranata R: Diabetes
mellitus is associated with increased mortality and severity of
disease in COVID-19 pneumonia-A systematic review, meta-analysis,
and meta-regression. Diabetes Metab Syndr. 14:395–403.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Onder G, Rezza G and Brusaferro S:
Case-Fatality rate and characteristics of patients dying in
relation to COVID-19 in Italy. JAMA. 323:1775–1776. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
de Almeida-Pititto B, Dualib PM,
Zajdenverg L, Dantas JR, de Souza FD, Rodacki M and Bertoluci MC:
Brazilian Diabetes Society Study Group (SBD). Severity and
mortality of COVID 19 in patients with diabetes, hypertension and
cardiovascular disease: A meta-analysis. Diabetol Metab Syndr.
12(75)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jeong IK, Yoon KH and Lee MK: Diabetes and
COVID-19: Global and regional perspectives. Diabetes Res Clin
Pract. 166(108303)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rajpal A, Rahimi L and Ismail-Beigi F:
Factors leading to high morbidity and mortality of COVID-19 in
patients with type 2 diabetes. J Diabetes. 12:895–908.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
McGurnaghan SJ, Weir A, Bishop J, Kennedy
S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM,
Mellor J, Jeyam A, et al: Risks of and risk factors for COVID-19
disease in people with diabetes: A cohort study of the total
population of Scotland. Lancet Diabetes Endocrinol. 9:82–93.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kheir M, Saleem F, Wang C, Mann A and Chua
J: Higher albumin levels on admission predict better prognosis in
patients with confirmed COVID-19. PLoS One.
16(e0248358)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kalbhande JG and Kuldeep V: Lymphopenia in
COVID-19 patients & its association with uncontrolled diabetes,
obesity and elderly: A perspective review. J Med Sci Clin Res.
8:398–401. 2020.
|
|
12
|
Man MA, Rajnoveanu RM, Motoc NS, Bondor
CI, Chis AF, Lesan A, Puiu R, Lucaciu SR, Dantes E, Gergely-Domokos
B and Fira-Mladinescu O: Neutrophil-to-lymphocyte ratio,
platelets-to-lymphocyte ratio, and eosinophils correlation with
high-resolution computer tomography severity score in COVID-19
patients. PLoS One. 16(e0252599)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang Q, Wei Y, Chen M, Wan Q and Chen X:
Clinical analysis of risk factors for severe COVID-19 patients with
type 2 diabetes. J Diabetes Complications.
34(107666)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wu J, Zhang J, Sun X, Wang L, Xu Y, Zhang
Y, Liu X and Dong C: Influence of diabetes mellitus on the severity
and fatality of SARS-CoV-2 (COVID-19) infection. Diabetes, Obes
Metab. 22:1907–1914. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Singh AK and Khunti K: Assessment of risk,
severity, mortality, glycemic control and antidiabetic agents in
patients with diabetes and COVID-19: A narrative review. Diabetes
Res Clin Pract. 165(108266)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Vijayam B, Balaji MS, Balaji T, Veerasamy
S and Devaraj S: Predicting the coronavirus disease 2019 severity
in patients with diabetes using hemoglobin A1c. Int J Sci Study.
9:64–67. 2021.
|
|
17
|
Merzon E, Green I, Shpigelman M, Vinker S,
Raz I, Golan-Cohen A and Eldor R: Haemoglobin A1c is a predictor of
COVID-19 severity in patients with diabetes. Diabetes Metab Res
Rev. 37(e3398)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Elnaem MH and Cheema E: Caring for
patients with diabetes during COVID-19 pandemic: Important
considerations for pharmacists. Res Soc Adm Pharm. 17:1938–1941.
2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
World Health Organization (WHO):
Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
Accessed September 16, 2020.
|
|
20
|
James PA, Oparil S, Carter BL, Cushman WC,
Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML,
MacKenzie TD, Ogedegbe O, et al: 2014 Evidence-based guideline for
the management of high blood pressure in adults report from the
panel members appointed to the Eighth Joint National Committee (JNC
8). JAMA. 311:507–520. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
American Diabetes Association (ADA).
Standards of Medical Care in Diabetes-2017. Diabetes Care. 40
(Suppl 1):S1–S2. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hayek S, Ben-Shlomo Y, Balicer R, Byrne K,
Katz M, Kepten E, Raz I, Roitman E, Zychma M, Barda N, et al:
Preinfection glycaemic control and disease severity among patients
with type 2 diabetes and COVID-19: A retrospective, cohort study.
Diabetes, Obes Metab. 23:1995–2000. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rudianto A, Soewondo P, Waspadji S, Yunir
E and Purnamasari D: The Indonesian Society of Endocrinology’s
Summary Article of Diabetes Mellitus National Clinical Practice
Guidelines. J ASEAN Fed Endocr Soc. 26(17)2011.
|
|
24
|
Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu
N, Gao Y, Ma J, Zhang H, Zhang J, et al: The clinical
characteristics and outcomes of patients with diabetes and
secondary hyperglycaemia with coronavirus disease 2019: A
single-centre, retrospective, observational study in Wuhan.
Diabetes, Obes Metab. 22:1443–1454. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang F, Yang Y, Dong K, Yan Y, Zhang S,
Ren H, Yu X and Shi X: Clinical characteristics of 28 Patients with
diabetes and COVID-19 in Wuhan, China. Endocr Pract. 26:668–674.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng
J, Li Q, Jiang C, Zhou Y, Liu S, et al: Risk factors of critical
& mortal COVID-19 cases: A systematic literature review and
meta-analysis. J Infect. 81:e16–e25. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Du P, Li D, Wang A, Shen S, Ma Z and Li X:
A systematic review and meta-analysis of risk factors associated
with severity and death in COVID-19 patients. Can J Infect Dis Med
Microbiol. 2021(6660930)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Setiati S, Harimurti K, Safitri ED,
Ranakusuma RW, Saldi SRF, Azwar MK, Marsigit J, Pitoyo Y and
Widyaningsih W: Risk factors and laboratory test results associated
with severe illness and mortality in COVID-19 patients: A
systematic review. Acta Med Indones. 52:227–245. 2020.PubMed/NCBI
|
|
30
|
Tay MZ, Poh CM, Rénia L, MacAry PA and Ng
LFP: The trinity of COVID-19: Immunity, inflammation and
intervention. Nat Rev Immunol. 20:363–374. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Apicella M, Campopiano MC, Mantuano M,
Mazoni L, Coppelli A and Del Prato S: COVID-19 in people with
diabetes: Understanding the reasons for worse outcomes. Lancet
Diabetes Endocrinol. 8:782–792. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Opal SM, Girard TD and Ely EW: The
immunopathogenesis of sepsis in elderly patients. Clin Infect Dis.
41 (Suppl 7):S504–S512. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Petrie JR, Guzik TJ and Touyz RM:
Diabetes, hypertension, and cardiovascular disease: Clinical
insights and vascular mechanisms. Can J Cardiol. 34:575–584.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu Z, Bai X, Han X, Jiang W, Qiu L, Chen
S and Yu X: The association of diabetes and the prognosis of
COVID-19 patients: A retrospective study. Diabetes Res Clin Pract.
169(108386)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gagliardi I, Patella G, Michael A, Serra
R, Provenzano M and Andreucci M: COVID-19 and the kidney: From
epidemiology to clinical practice. J Clin Med.
9(2506)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Conti P and Younes A: Coronavirus
COV-19/SARS-CoV-2 affects women less than men: Clinical response to
viral infection. J Biol Regul Homeost Agents. 34:339–343.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold
AP and Sandberg K: Sex differences in renal angiotensin converting
enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex
chromosome-independent. Biol Sex Differ. 1(6)2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Benjamin BK, Qiu C, Han Z, Lu W, Sun G,
Qin X, Wang X, Wang X, Li R and Pan L: The association between
type-2 diabetes duration and major adverse cardiac events after
percutaneous coronary intervention. J Diabetes Res. 2021:1–9.
2021.
|
|
39
|
International Diabetes Federation: IDF
Diabetes Atlas, ninth edition 2019. https://www.diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf.
|
|
40
|
Cariou B, Hadjadj S, Wargny M, Pichelin M,
Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B,
et al: Phenotypic characteristics and prognosis of inpatients with
COVID-19 and diabetes: The CORONADO study. Diabetologia.
63:1500–1515. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Varga Z, Flammer AJ, Steiger P, Haberecker
M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka
F and Moch H: Endothelial cell infection and endotheliitis in
COVID-19. Lancet. 395:1417–1418. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhang N, Wang C, Zhu F, Mao H, Bai P, Chen
LL, Zeng T, Peng MM, Qiu KL, Wang Y, et al: Risk factors for poor
outcomes of diabetes patients with COVID-19: A single-center,
retrospective study in early outbreak in China. Front Endocrinol
(Lausanne). 11(571037)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pranata R, Lim MA, Huang I, Raharjo SB and
Lukito AA: Hypertension is associated with increased mortality and
severity of disease in COVID-19 pneumonia: A systematic review,
meta-analysis and meta-regression. J Renin Angiotensin Aldosterone
Syst. 21(1470320320926899)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo
Q, Ji R, Wang H, Wang Y and Zhou Y: Prevalence of comorbidities and
its effects in patients infected with SARS-CoV-2: A systematic
review and meta-analysis. Int J Infect Dis. 94:91–95.
2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Mudatsir M, Fajar JK, Wulandari L,
Soegiarto G, Ilmawan M, Purnamasari Y, Mahdi BA, Jayanto GD,
Suhendra S, Setianingsih YA, et al: Predictors of COVID-19
severity: A systematic review and meta-analysis. F1000Research.
9(1107)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Callender LA, Curran M, Bates SM, Mairesse
M, Weigandt J and Betts CJ: The Impact of Pre-existing
Comorbidities and Therapeutic Interventions on COVID-19. Front
Immunol. 11(1991)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Azevedo RB, Botelho BG, Hollanda JVG,
Ferreira LVL, Junqueira de Andrade LZ, Oei SSML, Mello TS and
Muxfeldt ES: Covid-19 and the cardiovascular system: A
comprehensive review. J Hum Hypertens. 35:4–11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Colussi G, Da Porto A and Cavarape A:
Hypertension and type 2 diabetes: Lights and shadows about
causality. J Hum Hypertens. 34:91–93. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian
C, Qin R, Wang H, Shen Y, Du K, et al: Diabetes is a risk factor
for the progression and prognosis of COVID-19. Diabetes Metab Res
Rev. 36(e3319)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Siddiqi HK and Mehra MR: COVID-19 illness
in native and immunosuppressed states: A clinical-therapeutic
staging proposal. J Hear Lung Transplant. 39:405–407.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Windham S, Wilson MP, Fling C, Sheneman D,
Wand T, Babcock L, MaWhinney S and Erlandson KM: Elevated
glycohemoglobin is linked to critical illness in COVID-19: A
retrospective analysis. Ther Adv Infect Dis.
8(20499361211027390)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Klein OL, Krishnan JA, Glick S and Smith
LJ: Systematic review of the association between lung function and
type 2 diabetes mellitus. Diabet Med. 27:977–987. 2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Maan HB, Meo SA, Al Rouq F, Meo IMU,
Gacuan ME and Alkhalifah JM: Effect of glycated hemoglobin (HbA1c)
and duration of disease on lung functions in type 2 diabetic
patients. Int J Environ Res Public Health. 18(6970)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gautret P, Lagier JC, Parola P, Hoang VT,
Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE,
et al: Hydroxychloroquine and azithromycin as a treatment of
COVID-19: Results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 56(105949)2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Chou HW, Wang JL, Chang CH, Lee JJ, Shau
WY and Lai MS: Risk of severe dysglycemia among diabetic patients
receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Clin Infect Dis. 57:971–980. 2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Chen C, Zhang Y, Zhao X, Tao M, Yan W and
Fu Y: Hypoalbuminemia-an indicator of the severity and prognosis of
COVID-19 patients: A multicentre retrospective analysis. Infect
Drug Resist. 14:3699–3710. 2021.PubMed/NCBI View Article : Google Scholar
|
